RA CAPITAL MANAGEMENT, L.P. - 29 Jun 2021 Form 4 Insider Report for Therapeutics Acquisition Corp.

Role
Director
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol
N/A
Transactions as of
29 Jun 2021
Net transactions value
+$2,091,000
Form type
4
Filing time
30 Jun 2021, 16:30:22 UTC
Previous filing
24 Jun 2021
Next filing
30 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PNT Common Stock Purchase $2,091,000 +209,100 +24% $10.00 1,098,318 29 Jun 2021 See Footnotes F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RA Capital Healthcare Fund, L.P. (the "Fund") acquired 209,100 shares of common stock of the issuer on 6/29/21 for a price of $10 per share.
F2 These securities are held directly by the Fund.
F3 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Remarks:

Dr. Kolchinsky, a managing member of the Adviser, is the Chief Executive Office and sits on the Board of Directors of the Issuer. Additionally, Matthew Hammond, a Principal of the Adviser, is the Chief Financial Officer and sits on the Board of Directors of the Issuer.